In Contentious Meeting, SACGHS Tackles Gene-Association Patentability, Impact of Exclusive Licenses | GenomeWeb

By Turna Ray

A high-profile government advisory committee was minutes away last week from formally recommending that HHS Secretary Kathleen Sebelius support statutory changes limiting the practice of patenting claims on genes — but at the very end of a one-and-a-half-day meeting on gene patenting, the HHS Secretary's Advisory Committee on Genetics, Health, and Society decided to hold off on voting on the group's recommendations until the opinions of dissenting members were incorporated into the full report.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.